Skip to main content

Table 3 Prognostic value of NUCB2 protein expression for the BCR-free survival in univariate and multivariate analyses by Cox regression

From: Prognostication of prostate cancer based on NUCB2 protein assessment: NUCB2 in prostate cancer

Covariant Univariate analysis Multivariate analysis
Exp (B) 95% CI P value Exp (B) 95% CI P value
NUCB2 protein expression (high/low) 2.306 1.501-3.544 <0.001 2.535 1.643-3.911 <0.001
Gleason score (> 7/7/< 7) 1.703 1.280-2.265 <0.001 1.846 1.384-2.460 <0.001
PSA (>10/4-10/< 4) 1.241 0.705-2.188 0.454    
Age (≥65/< 65) 1.068 0.804-1.419 0.650    
Angiolymphatic invasion (presence/absence) 1.084 0.814-1.443 0.580    
Surgical margin status (presence/absence) 1.017 0.709-1.459 0.925    
PCa Stage (T2, T3/T1) 1.090 0.921-1.291 0.316    
Lymph node metastasis (presence/absence) 1.140 0.850-1.528 0.381    
Seminal vesicle invasion (presence/absence) 1.505 1.132-2.003 0.005 1.538 1.154-2.048 0.003